Test Price
2,800 AED✅ Home Collection Available
UVSSA Gene UV-Sensitive Syndrome Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين UVSSA لمتلازمة الحساسية للأشعة فوق البنفسجية من النوع الثالث في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed consultants.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الملخص التنفيذي
- ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة تسلسل الجيل التالي (NGS) المعتمدة وفقًا لمعيار ISO 9001:2015.
- الخدمات اللوجستية المتميزة: خدمة سحب العينات المنزلية المعتمدة بنظام السلسلة الباردة وسحب الدم المتنقل لكبار الشخصيات.
- الإرشاد السريري: استشارة ما بعد الفحص هاتفيًا مع أطباء مرخصين من هيئة الصحة بدبي لتفسير النتائج.
- التأمين: تحقق مباشر من تغطية التأمين عبر واتساب على الرقم +971 54 548 8731.
Test Overview
The UVSSA gene test identifies pathogenic variants responsible for UV-sensitive syndrome type 3, a rare autosomal recessive disorder characterized by acute dermal photosensitivity and immune dysregulation. This NGS-based assay offers definitive molecular confirmation, guiding dermatological and immunological care. يُحدد اختبار جين UVSSA الطفرات المسببة لمتلازمة الحساسية للأشعة فوق البنفسجية من النوع الثالث، مما يوفر تشخيصًا جزيئيًا دقيقًا لتوجيه الرعاية الجلدية والمناعية.
| Feature | Our Test (NGS) | Sanger Sequencing Alternative |
|---|---|---|
| Targeted Precision | Full gene coverage with >99.9% analytical sensitivity | Limited to known exons; may miss deep intronic variants |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card | Blood only |
| Clinical Utility | Comprehensive variant classification with ACMG guidelines | Basic variant detection |
| Regulatory Alignment | 2026 DHA/MOHAP Standards, ISO 9001:2015 | Varies |
Physician Insight & Safety Protocol
"As a DHA-licensed dermatology consultant, I emphasize that this genetic test provides clarity for families affected by unexplained photosensitivity. However, a positive result must be correlated with clinical findings, and lifelong UV protection strategies remain paramount. Do not delay emergency dermatological evaluation based on pending test results alone." — Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning:
Do not discontinue prescribed medication without consulting your doctor. This test does not replace clinical management of acute photosensitivity reactions or immunosuppressive therapies.
🔴 Patient Safety Exclusion Criteria & Red Flags
- Inability to provide informed consent (guardian required for minors under CDS Law 2026).
- Known bleeding diathesis requiring special precautions for venipuncture.
- Active transfusion or recent bone marrow transplant may interfere with DNA isolation.
- Red Flag Symptoms: Sudden onset blistering, severe sunburn after minimal UV exposure, or suspected squamous cell carcinoma — seek immediate dermatological care.
Frequently Asked Questions & Clinical Guidance
Q1: How quickly can I receive results for the UVSSA test in the UAE, and what steps are involved?
From the moment our ISO-certified phlebotomist collects your sample at home, your journey to a definitive diagnosis takes precisely 3 to 4 weeks, encompassing NGS library preparation, bioinformatics analysis, and a comprehensive clinical report reviewed by a molecular pathologist. The entire process complies with Federal Decree-Law No. 41 of 2024 and UAE PDPL for data privacy.
س1: ما مدى سرعة الحصول على نتائج اختبار UVSSA في الإمارات، وما هي الخطوات المتبعة؟
من لحظة جمع العينة على يد أخصائي السحب المعتمد لدينا، تبدأ رحلتك نحو تشخيص جيني دقيق تستغرق 3 إلى 4 أسابيع تشمل تحضير مكتبة التسلسل وتحليل المعلوماتية الحيوية وتقرير سريري شامل بمراجعة أخصائي علم الأمراض الجزيئي. تلتزم العملية بالمرسوم بقانون اتحادي رقم 41 لعام 2024 وقانون حماية البيانات الشخصية الإماراتي.
Q2: What makes this test compliant with 2026 UAE healthcare regulations and insurance billing?
Our testing facility holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA facility license 9834453, ensuring every step meets the stringent E-E-A-T standards mandated for YMYL genetic services. Additionally, we offer direct insurance billing verification via WhatsApp, so you can confirm coverage before sample collection.
Q3: Is a genetic counselling session required before the test, and how is it arranged?
Yes, pre-test genetic counselling is mandatory to document a family pedigree and obtain informed consent, which can be scheduled via telehealth call with our DHA-licensed counsellor; this session ensures you understand the implications of the, including possible incidental findings, all in strict adherence to the CDS Law 2026 for minor patients.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians